1. Home
  2. ARCB vs EVO Comparison

ARCB vs EVO Comparison

Compare ARCB & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCB
  • EVO
  • Stock Information
  • Founded
  • ARCB 1923
  • EVO 1993
  • Country
  • ARCB United States
  • EVO Germany
  • Employees
  • ARCB N/A
  • EVO N/A
  • Industry
  • ARCB Trucking Freight/Courier Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARCB Industrials
  • EVO Health Care
  • Exchange
  • ARCB Nasdaq
  • EVO Nasdaq
  • Market Cap
  • ARCB 1.9B
  • EVO 1.6B
  • IPO Year
  • ARCB N/A
  • EVO 2021
  • Fundamental
  • Price
  • ARCB $69.49
  • EVO $3.32
  • Analyst Decision
  • ARCB Buy
  • EVO Buy
  • Analyst Count
  • ARCB 13
  • EVO 2
  • Target Price
  • ARCB $107.00
  • EVO $5.90
  • AVG Volume (30 Days)
  • ARCB 314.6K
  • EVO 115.7K
  • Earning Date
  • ARCB 04-29-2025
  • EVO 05-21-2025
  • Dividend Yield
  • ARCB 0.68%
  • EVO N/A
  • EPS Growth
  • ARCB N/A
  • EVO N/A
  • EPS
  • ARCB 7.31
  • EVO N/A
  • Revenue
  • ARCB $4,179,019,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • ARCB $4.67
  • EVO $3.70
  • Revenue Next Year
  • ARCB $7.02
  • EVO $10.32
  • P/E Ratio
  • ARCB $9.73
  • EVO N/A
  • Revenue Growth
  • ARCB N/A
  • EVO N/A
  • 52 Week Low
  • ARCB $68.83
  • EVO $2.85
  • 52 Week High
  • ARCB $153.60
  • EVO $7.98
  • Technical
  • Relative Strength Index (RSI)
  • ARCB 29.98
  • EVO 31.12
  • Support Level
  • ARCB $72.77
  • EVO $3.25
  • Resistance Level
  • ARCB $75.08
  • EVO $3.63
  • Average True Range (ATR)
  • ARCB 2.60
  • EVO 0.09
  • MACD
  • ARCB 0.48
  • EVO -0.00
  • Stochastic Oscillator
  • ARCB 9.89
  • EVO 16.28

About ARCB ArcBest Corporation

ArcBest Corp is engaged in logistics operations. The company operates in two operating segments, The Asset-Based segment includes the results of operations of ABF Freight System, Inc. and certain other subsidiaries. The segment operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed LTL services. The services including freight transportation related to managed transportation solutions and other services. The Asset-Light segment includes the results of operations of the Company's service offerings in truckload, ground expedite, dedicated, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: